An editorial in Nature argues the case for drug-based cognitive enhancement for both the healthy and the unwell.

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1621, 2008-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The drug-based pipeline against restenosis

By Keller Pierre-Frédéric Ibrahim Reda Tardif Jean-Claude

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 67-86

Informa Healthcare

Access to resources Recommend Favorite

Broadening the clinical use of platinum drug–based chemotherapy with new analogues

By Kelland Lloyd

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-06 ,pp. : 1009-1021

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Cognitive Enhancement: Are we Barking Up the Wrong Tree?)

Current Drug Abuse Reviews, Vol. 5, Iss. 4, 2012-12 ,pp. : 255-256

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: HSA-Based Drug Development and Drug Delivery Systems)

Current Pharmaceutical Design, Vol. 21, Iss. 14, 2015-04 ,pp. : 1784-1784

Bentham Science Publishers

Access to resources Recommend Favorite

Dopaminergic Enhancement of Cognitive Function

Current Pharmaceutical Design, Vol. 12, Iss. 20, 2006-07 ,pp. : 2487-2500

Bentham Science Publishers

Access to resources Recommend Favorite